Minoryx Therapeutics
PrivateLast Round
Grant
May 28, 2024
Total Funding Raised
$137.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Minoryx Therapeutics is a clinical-stage biotechnology company that discovers and develops novel treatments for severe, orphan diseases of the central nervous system (CNS) with high unmet medical need.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minoryx Therapeutics Comparables
Compare Minoryx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Poxel SA | 73% | |
| Viking Therapeutics, Inc. | 72% | |
| Spur Therapeutics | 71% |
Minoryx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2024 | ||||
| Series C | May 31, 2022 | ||||
| Debt | Oct 30, 2020 | ||||
| Series B | Sep 26, 2018 | ||||
| Series A | Oct 14, 2015 | ||||
Seed | Oct 1, 2015 |
Minoryx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series B, Series C |
| Roche Venture Fund | Series B, Series A, Series C |
| CDTI Innvierte | Series C |
| Fund+ | Series C, Series B |
| Ysios Capital | Series B, Series C, Series A |
| Wallonie Entreprendre | Series B, Series C |
| Horizon 2020 Programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 44% MoM, reaching 6.9K.
- Jan 25, 2026
Monthly visitors grew 107% MoM, reaching 9.6K.
Minoryx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Minoryx Therapeutics's valuation, stock price, and market status.
Is Minoryx Therapeutics a public or private company?
Minoryx Therapeutics is a private company.
What is the current stock price of Minoryx Therapeutics?
Minoryx Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Minoryx Therapeutics worth (valuation)?
Valuation information for Minoryx Therapeutics is not publicly available.
Can I buy Minoryx Therapeutics stock?
Minoryx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Minoryx Therapeutics's last funding round?
Minoryx Therapeutics's most recent funding round was Grant on May 28, 2024.
Who are the main investors in Minoryx Therapeutics?
Key investors in Minoryx Therapeutics include Fund+, Ysios Capital, Caixa Capital Risc, Columbus Venture Partners.
Will Minoryx Therapeutics IPO soon?
No public IPO plans have been announced for Minoryx Therapeutics.
How can I track Minoryx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Minoryx Therapeutics's secondary market activity and sign up for updates.